Myth: ADHD is Overdiagnosed

The claim that ADHD is overdiagnosed appears regularly in opinion writing, in commentary from non-specialist clinicians, and in family conversations where someone is sceptical about a recent diagnosis. The intuition behind the claim is that we are diagnosing today what we did not diagnose a generation ago, and that the gap must mean we are over-detecting.

The research literature, looked at carefully, says something close to the opposite. ADHD is, on the available evidence, under-diagnosed almost everywhere, including in India. The increase in diagnoses over the past three decades reflects improving recognition catching up to the underlying prevalence, rather than over-detection of a condition that is not really there.

What “overdiagnosed” would actually mean

For a condition to be overdiagnosed in a meaningful sense, two things need to be true:

• The clinical diagnosis is being applied to people who do not, on careful evaluation, meet criteria for the condition.
• The pattern of over-application is producing harm: unnecessary medication, missed alternative diagnoses, stigma.

This is a real possibility for any clinical condition. The question for ADHD is whether the available data supports the claim.

What the international data shows

A few headline numbers:

• Population-based prevalence estimates for childhood ADHD across countries cluster around five to seven per cent, with some variation by methodology.
• Population-based prevalence estimates for adult ADHD cluster around two to three per cent.
• Diagnosis rates in most countries are below these estimates. The United States is the country most often pointed to as overdiagnosing, and even there, multiple analyses suggest that the actual diagnosis rates approach but do not exceed underlying prevalence in most groups, with substantial variation by region.
• Girls and women are diagnosed at lower rates than the prevalence ratios in epidemiological samples would predict. This is consistent across countries.
• Adults are diagnosed at substantially lower rates than the prevalence figures would predict, again consistent across countries.

In aggregate, the international research is more consistent with under-diagnosis than over-diagnosis.

What the Indian data shows

Indian data is patchier than international data, because there is no nationally representative epidemiological study of ADHD prevalence. The available evidence comes from clinical samples at tertiary centres, smaller community studies, and a small number of multi-site studies.

What it suggests:

• Indian clinical samples show male-to-female ratios for childhood ADHD diagnosis that are far wider than the underlying prevalence ratio. Reported clinical-sample ratios in Indian studies often run 5:1 or higher; the underlying prevalence ratio is closer to 2:1. The implication: girls are substantially under-diagnosed in India.
• Indian clinical samples show very few adult ADHD presentations relative to what international prevalence figures would predict for the Indian adult population. The implication: adults are substantially under-diagnosed in India.
• Indian rural samples show even lower diagnosis rates relative to expected prevalence than urban samples. The implication: rural Indians are particularly under-diagnosed.

Why the “overdiagnosed” intuition persists

If the data points to under-diagnosis, why does the overdiagnosis claim feel intuitive to so many people?

A few reasons:

• Generational comparison bias. People remember that ADHD was rare in their childhood and conclude that today’s higher diagnosis rates must be inflated. The more accurate explanation is that recognition has improved.
• Visibility bias. A few high-profile cases of arguably questionable ADHD diagnosis (often in commentary, not in the clinical literature) get more attention than the much larger pool of unrecognised cases.
• Confusion with stimulant misuse. Stimulant misuse, particularly among university students and competitive-examination aspirants, is a real phenomenon. This is a separate problem from ADHD diagnosis, but the two get conflated in commentary.
• Cultural framing. There is real cultural resistance, in many countries including India, to the medicalisation of behaviour. The “we are pathologising normal childhood” frame appeals to that resistance even where the evidence does not support it.

What this means in practice

A few practical implications:

• If you are an adult in India who suspects you have ADHD but have been told by a non-specialist that “everyone has those symptoms” or “ADHD is overdiagnosed”, that is not, on the evidence, a good reason to delay clinical evaluation.
• If you are the parent of a girl with attention difficulties and the school has not flagged any concern, that is consistent with the broader pattern of girls being under-flagged. A clinical evaluation is a reasonable next step regardless of school silence.
• If you are sceptical of an ADHD diagnosis in your family or social circle, a careful look at the actual clinical evaluation that produced the diagnosis is a more useful response than a general “ADHD is overdiagnosed” frame.

When the overdiagnosis concern has merit

The overdiagnosis concern is not entirely empty. Specific contexts where it has clinical force:

• Brief consultations by non-specialists that produce a diagnosis without adequate history-taking, collateral information, or screening for alternative explanations. This is a quality-of-care issue, not an overdiagnosis-of-ADHD issue.
• Stimulant prescribing without proper diagnostic evaluation. This is a regulatory issue.
• Self-diagnosis without clinical evaluation. This is a separate problem.

These are real concerns, addressable through better clinical practice. They do not support the broad claim that ADHD is overdiagnosed at the population level.

Frequently asked questions

Has the rise in ADHD diagnoses been gradual or sudden?

Gradual, over decades. The curve broadly tracks improving awareness and changes in diagnostic criteria. There is no evidence of a single inflection point that would suggest a fad.

Are children being prescribed stimulants who do not need them?

Almost certainly some are. The relevant policy response is better diagnostic practice, not denying treatment to the much larger group who are not getting it.

Is the diagnostic criteria too broad?

DSM-5 broadened some criteria slightly compared to DSM-IV, with corresponding modest increases in measured prevalence. The change is small relative to the underlying prevalence-detection gap.

Does the diagnosis label children unnecessarily?

The risk of labelling is real and worth taking seriously, particularly in how the diagnosis is communicated to the child. The risk of not labelling, when the underlying pattern is producing real difficulty, is also real and substantially larger in most cases.

Sources

• Polanczyk, G., et al. (2007). The worldwide prevalence of ADHD. American Journal of Psychiatry.
• Faraone, S. V., et al. World Federation of ADHD International Consensus Statement (2021).
• Indian Journal of Psychiatry clinical-sample prevalence studies.
• World Mental Health Survey Initiative on adult ADHD.